Conclusion of a non-exclusive rebate agreement for medicinal products containing biperiden

Summary

The tender concerns the conclusion of a non-exclusive rebate agreement for medicinal products containing the active substance biperiden for the period 1 September 2026 to 31 August 2028, with an option to extend the contract once for 12 months. A bidder should note that DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible, and the exact participation requirements must be checked in the tender documents.